Results from two early-phase trials presented at the American Society of Clinical Oncology suggest that an immunotherapy using genetically engineered immune cells may be effective in patients with advanced multiple myeloma.
from Cancer via ola Kala on Inoreader http://ift.tt/2sjYS0K
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου